Lallemand Invests in Enzyme Firm Livzym, Expanding Alternatives to Proteins, Chemicals & Sugar
Canada’s Lallemand Bio-Ingredients announces an equity investment through its Swiss affiliate, Danstar Ferment AG, in Livzym Biotechnologies, a Turkish company specializing in fungi-based enzymes for industrial use. With additional equity from Turkish investors, the funds will help finance the expansion of Livzym’s production plant in Tuzla, near Istanbul, to meet the increasing demand for sustainable enzymes across a wide range of industries, including food, textile, paper, animal feed, and biofuels. Lallemand Bio-Ingredients president Lars Asferg, shares, “We are committed to making biotechnology one of the answers to the challenges the world faces concerning nutrition, health, and the environment. The inclusion of Livzym’s enzymes within Lallemand’s portfolio will enable us to offer our customers an exciting range of high-performance enzymes.” Strategic collaboration As part of the strategic …